Expression and clinical value of MGMT and EGFR in laryngeal squamous cell carcinoma

Xiaocheng ZHU,Xiaoyun QIAN,Yajun GU,Xiaohui SHEN,Panpan SONG,Hui LI,Xia GAO

DOI: https://doi.org/10.6040/j.issn.1673-3770.0.2017.116

2017-01-01

Abstract:Objective To investigate the relationship between expression of O6-methylguanine-DNA methyltransferase (MGMT) and epidermal growth factor receptor (EGFR) in laryngeal squamous cell carcinoma (LSCC),and their relationship with clinicopathological features.Methods We collected 103 tumor tissues,detected the expression of MGMT and EGFR by immunohistochemistry (IHC),and explored their relationship with the clinicopathological features.Results The expression of MGMT in tumor tissues was positively related to differentiation degree,T stage,and clinical stage (x2 13.302,8.394,11.403,P =0.001,0.039,and 0.010,respectively).The expression of EGFR in tumor tissue was positively correlated with T stage and clinical stage (x2 =14.933,16.603,P =0.002,and 0.001,respectively).Further analysis found that the expression levels of MGMT and EGFR were positively correlated (MGMT vs EGFRx2 =5.369,P =0.019).Conclusion The expression of MGMT and EGFR was correlated with T stage and clinical stage.Detecting their expression can assist in assessing the malignancy of LSCC and guide treatment.